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Introduction
Lipoxygenases (LOXs) represent a widely distributed family 
of nonheme, nonsulfur, iron-containing dioxygenases that 
  catalyze the regioselective and stereoselective dioxygenation 
of fatty acid substrates containing one or more (Z,Z)-1,4-
 pentadiene moieties (Brash, 1999). Within the mammalian LOX 
family, a distinct subclass of epidermis-type LOX has been 
characterized that are preferentially expressed in skin and few 
other epithelial tissues (Krieg et al., 2002). They include the 
human 15-LOX-2 and its mouse orthologue 8-LOX, 12R-LOX, 
and eLOX-3. Their genes map close together within a gene 
cluster on human chromosome 17p13.1 that was found highly 
conserved within a syntenic region at the central region of 
mouse chromosome 11 (Krieg et al., 2001). Although exhibit-
ing a rather heterogeneous regio- and stereospecifi  city, the epi-
dermis-type LOX are phylogenetically closely related, sharing 
 50% amino acid identity. Their differentiation-dependent ex-
pression pattern in epithelial tissues suggests a common physio-
logical role in the regulation of proliferation and differentiation 
of epithelial cells, especially keratinocytes.
The epidermal 12R-LOX and eLOX-3 differ from all other 
mammalian LOX in their unique structural and enzymatic fea-
tures (Boeglin et al., 1998; Krieg et al., 1999; Kinzig et al., 1999). 
Both proteins contain an extra domain located at the surface of the 
catalytic subunit. 12R-LOX represents the only mammalian LOX 
that forms products with R-chirality, and, unlike all other LOX, 
eLOX-3 does not exhibit dioxygenase activity, but functions as a 
hydroperoxide isomerase (Yu et al., 2003). Both enzymes act in 
sequence to convert arachidonic acid via 12R-hydroperoxyeico-
satetraenoic acid (12R-HPETE) to the corresponding hepoxilin-
like epoxyalcohol, 8R-hydroxy-11R,12R-epoxyeicosatrienoic 
acid. This sequence has been hypothesized to be part of a novel 
LOX pathway in skin that plays an important role in terminal dif-
ferentiation (Jobard et al., 2002; Yu et al., 2003).
Recent genetic studies have identifi  ed mutations in the 
coding regions of 12R-LOX and eLOX-3 genes in patients with 
autosomal recessive congenital ichthyosis (ARCI), linking for 
the fi  rst time mutations of a LOX gene to the development of a 
disease (Jobard et al., 2002; Eckl et al., 2005). ARCI is a clini-
cally and genetically heterogeneous group of skin disorders that 
is associated with hyperkeratosis and impaired skin barrier 
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2R-lipoxygenase (12R-LOX) and the epidermal 
LOX-3 (eLOX-3) constitute a novel LOX pathway 
involved in terminal differentiation in skin. This 
view is supported by recent studies showing that inacti-
vating mutations in 12R-LOX and eLOX-3 are linked to 
the development of autosomal recessive congenital ich-
thyosis. We show that 12R-LOX deﬁ  ciency in mice results 
in a severe impairment of skin barrier function. Loss of 
barrier function occurs without alterations in proliferation 
and stratiﬁ  ed organization of the keratinocytes, but is 
associated with ultrastructural anomalies in the upper 
granular layer, suggesting perturbance of the assembly/
extrusion of lamellar bodies. Corniﬁ   ed envelopes from 
skin of 12R-LOX–deﬁ  cient mice show increased fragility. 
Lipid analysis demonstrates a disordered composition 
of ceramides, in particular a decrease of ester-bound 
ceramide species. Moreover, processing of proﬁ  laggrin to 
monomeric ﬁ  laggrin is impaired.
This study indicates that the 12R-LOX–eLOX-3 path-
way plays a key role in the process of epidermal barrier 
acquisition by affecting lipid metabolism, as well as 
  protein processing.
Correspondence to Peter Krieg: p.krieg@dkfz.de
Abbreviations used in this paper: ARCI, autosomal recessive congenital ich-
thyosis; CE, corniﬁ  ed envelope; E, embryonic day; eLOX-3, epidermis-type LOX-3; 
ES, embryonic stem; HPETE, hydroperoxyeicosatetraenoic acid; LOX, lipoxy-
genase; PPAR, peroxisome proliferator-activated receptor; TEWL, transepidermal 
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functions (Traupe, 1989). We and others recently showed that 
the point mutations found in the LOX genes of the ARCI  patients 
completely eliminated the catalytic activity of the LOX en-
zymes, indicating that mutational inactivation of either 12R-
LOX or eLOX-3 is causally linked to the ARCI phenotype (Eckl 
et al., 2005; Yu et al., 2005).
To investigate the physiological role of 12R-LOX and to 
analyze the molecular mechanisms that underlie the ichthyosi-
form skin phenotype, we developed mice with targeted inacti-
vation of the 12R-LOX gene. Examination of the resulting 
phenotype has revealed a crucial role of 12R-LOX in the devel-
opment of epidermal barrier function, demonstrating for the 
fi  rst time an indispensable function of a LOX isoform for post-
natal survival of mice.
Results
Generation of 12R-LOX–deﬁ  cient mice
For targeting the Alox12b gene, we used the Cre-loxP system. A 
targeting vector was constructed by placing a resistance cassette 
fl  anked by loxP sites into intron 7 of Alox12b. A third loxP site 
was inserted downstream of exon 8 (Fig. 1 A). This exon en-
codes a highly conserved region containing two of the iron-
binding histidines that are absolutely required for LOX catalytic 
activity (Brash, 1999; Krieg et al., 1999). Thus, Cre-mediated 
excision of this region yields a nonfunctional protein. The tar-
geting construct was electroporated into E14 embryonic stem 
(ES) cells, followed by G418 selection. Two ES cell clones had 
correctly recombined alleles and were used to generate germ-
line chimeras. Heterozygous fl  oxed mice (Alox12b
+/fl  ox) were 
mated with CMV-Cre deleter mice (Schwenk et al., 1995) to 
validate our construct and to generate mice harboring a dis-
rupted Alox12b allele. Correct recombination and complete ex-
cision of the resistance cassette and exon 8 were confi  rmed by 
PCR analysis and Southern blot analysis, yielding the expected 
BamHI fragments (Fig. 1, B–D). Heterozygous Alox12b
+/− 
mice were intercrossed to generate homozygous mutant mice. 
Genotype analysis of 112 newborns from 19 intercrosses dem-
onstrated that wild-type, heterozygous, and homozygous mu-
tant mice were produced in the expected Mendelian ratios, 
indicating no embryonic lethality of the Alox12b
−/−mice.
RT-PCR and Western blot analysis demonstrated the ex-
pression of 12R-LOX RNA and protein in skin isolated from 
neonatal mice. The mutated Alox12b RNA lacking exon 8 was 
expressed in heterozygous and homozygous newborn mice, and 
no wild-type RNA was detected in skin from homozygous mu-
tant mice (Fig. 2 A). Wild-type 12R-LOX protein was detected 
in epidermis of wild-type and heterozygous mice, but was ab-
sent in the skin of homozygous Alox12b
−/− mice. A predicted 
truncated 12R-LOX was not detectable, indicating translational 
suppression or instability of the mutated protein (Fig. 2 B). The 
lack of 12R-LOX protein expression in the skin of homozygous 
Figure 1.  Generation of 12R-LOX–deﬁ  cient  mice.  (A) 
Strategy of Alox12b gene targeting. B, BamHI; neo, the 
neomycin phosphotransferase gene; tk, the thymidine 
  kinase gene. LoxP sites are depicted as open triangles. 
Probes a and b were used to identify recombinant and 
deleted alleles. (B) Southern blot analysis of BamHI-
  digested DNA from wild-type (+/+) mice (lanes 1 and 5), 
from ES cells (lanes 2 and 6), and from heterozygous mice 
(lanes 3, 4, 7, and 8) carrying the ﬂ  oxed allele (+/ﬂ  ). 
Detection of an 8.7-kb fragment using probe a (left) and a 
4.8-kb fragment using probe b (right) revealed the pres-
ence of the correct recombinated allele. (C) Southern blot 
analysis of BamHI-digested DNA from wild-type (+/+), 
heterozygous (+/−), and homozygous (−/−) mice 
carrying the ﬂ  oxed-deleted allele. Detection of a 9.8-kb 
fragment using probe a (left) and probe b (right) revealed 
the correct excision of the resistance cassette and exon 8. 
(D) PCR genotype analysis of tail DNA. Primer combina-
tion ol1231/ol709 was used, amplifying a 1,075-bp 
product of the wild type and a 459-bp product of the 
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mutant mice was confi  rmed by immunofl  uorescence. Using a 
12R-LOX–specifi   c mAb, a prominent and specifi  c  staining 
throughout the plasma membranes of keratinocytes in the stra-
tum granulosum was seen in wild-type mice, but was absent in 
the homozygous mutant mice (Fig. 2 C).
Loss of skin barrier function in 12R-LOX–
deﬁ  cient mice
Heterozygous Alox12b
+/− mice were phenotypically indistin-
guishable from wild-type mice and reproduced normally. At 
birth, Alox12b
−/− mice were hard to distinguish from wild-type 
and heterozygous littermates upon macroscopic inspection. 
However, their skin soon began to develop a red, shiny appear-
ance and became somewhat sticky to the touch (Fig. 3 A). The 
neonates did not feed and became progressively dehydrated. All 
homozygous mutant mice died within 3–5 h after birth.
The macroscopic appearance and the early neonate death 
of the mice suggested a perturbed water barrier. Weighing ex-
periments showed that homozygous Alox12b
−/− mice lost 
 30% of their body weight within 3 h, whereas their heterozy-
gous and wild-type littermates maintained their weight (Fig. 3 B). 
Transepidermal water loss (TEWL) of homozygous mutant 
mice was increased by a factor of  8 compared with wild-type 
and heterozygous littermates (Fig. 3 C). Thus, the lethal pheno-
type of the 12R-LOX–defi  cient mice most likely resulted from 
water loss as a result of impaired epidermal barrier function.
Barrier formation that starts around E16 in a patterned 
fashion (Hardman et al., 1998) was measured with a whole-
mount skin toluidine blue penetration assay. In wild-type 
animals, the staining pattern reflects the decrease of skin 
permeability from embryonic day (E) 16.5 to E17.5, when the 
barrier development proceeds in a dorsal to ventral pattern, up 
to E18.5, which is when skin has become completely imper-
meable. Skin of homozygous mutant mice, in contrast, re-
mained permeable, as indicated by intense staining (Fig. 4 A). 
We then assessed the permeability of the newborn epidermal 
barrier from outside using the fl  uorescent dye Lucifer yellow. 
In skin of 12R-LOX–defi  cient mice, the dye was found to pen-
etrate throughout the stratum corneum, whereas it was retained 
in the very top layers in the skin of wild-type mice (Fig. 4 B). 
These fi  ndings clearly indicate that both the inside-out and 
the outside-in water barrier function were severely affected in 
the epidermis of 12R-LOX–defi  cient mice. We also assessed the 
barrier function of tight junctions by injecting newborn mice 
subcutaneously with biotin and measuring its diffusion into 
the epidermis. Prevention of diffusion was observed in the up-
per granular cells of the skin of homozygous mutant mice, as 
well as in wild-type mice, indicating that 12R-LOX defi  ciency 
did not affect the barrier function of tight junctions (unpub-
lished data).
Defective processing of proﬁ  laggrin 
to ﬁ  laggrin monomers
The epidermis of newborn Alox12b
−/− mice did not exhibit 
overt abnormalities in the stratifi  ed organization of keratinocytes 
Figure 2.  The targeted deletion in the Alox12b-gene generates a null 
  mutation. (A) Detection of wild-type and mutant 12R-LOX mRNA in neonatal 
skin by RT-PCR. Primer combination ol230/ol709 was used to amplify a 
346-bp product of the wild type and a 142-bp product of the deleted allele. 
(B) Loss of 12R-LOX protein in neonatal skin of 12R-LOX
−/− mice examined 
by Western blot analysis using a polyclonal antiserum raised against a 
12R-LOX–speciﬁ  c peptide (top). As a control, the cell lysate of HEK 293 
transfectants exogenously expressing m12R-LOX was used. An antibody 
recognizing actin was used as a control for equal loading (bottom). (C) In 
wild-type mice, immunostaining using a 12R-LOX–speciﬁ   c mAb shows 
prominent staining of the plasma membranes of the keratinocytes in the 
granular layers subjacent to the stratum corneum. In 12R-LOX
−/− mice, 
these structures appear negative for such a staining. Nuclei are counter-
stained with Hoechst 33258. sc, stratum corneum; sg, stratum granulosum; 
ss, stratum spinosum; sb, stratum basale. Bars, 20 μm. 
Figure 3.  Impairment of the epidermal barrier in 12R-LOX
−/− mice. (A) 
Macroscopic appearance of wild-type and 12R-LOX
−/− mice at birth, and 
2 and 3 h after birth. Note the red, shiny skin and the dehydrated appear-
ance of 12R-LOX
−/− mice. (B) Dehydration assay over time. Data are pre-
sented as the percentage of initial body weight in wild-type (+/+, n = 6), 
heterozygous (+/−, n = 9), and homozygous (−/−, n = 11) mu-
tant  mice. Only homozygous mutant showed a 10% weight loss/h. 
(C) TEWL assay measured on ventral surface of newborn wild-type (+/+, 
n = 9), heterozygous (+/−, n = 18), and homozygous (−/−, n = 15) 
mutant mice.JCB • VOLUME 177 • NUMBER 1 • 2007  176
at the level of hematoxylin and eosin–stained paraffi  n section 
  images (Fig. 5). No substantial differences were observed in 
the basal, spinous, or granular layers. The stratum corneum, 
however, appeared to be more tightly packed compared with 
that of control skin. To unveil defects in differentiation, we 
analyzed the level of expression and distribution of terminal 
differentiation markers. Western blot analysis revealed that 
the levels of keratin 5 and 10, loricrin, and involucrin were 
not altered in the Alox12b-null versus control mice (Fig. 6). 
However, a complete loss of fi  laggrin monomer in knock-
out epidermis was associated with enhanced levels of pro-
teolytically derived intermediates, indicating that proteolytic 
processing of profi  laggrin was impaired. On the other hand, 
immunofluorescence showed a comparable distribution of 
the fi  laggrin expression in both genotypes. Similarly, other 
markers for epidermal differentiation, such as repetin and des-
mosomal proteins (claudin and occludin), revealed staining 
profi  les that did not differ between the 12R-LOX–defi  cient 
mice and their wild-type counterparts (unpublished data). 
Immunofl  uorescence analysis indicated absence of the hyper-
proliferative keratin 6. Accordingly, the proliferation index 
as determined by Ki67 staining was also unchanged (45.4 ± 
3.2% vs. 46.4 ± 0.6% in control and knockout mice, respec-
tively). This indicates that basal cell proliferation was un-
affected. The structure of the hair follicles also seemed to 
be normal.
Structural abnormalities in skin 
of 12R-LOX–deﬁ  cient mice
Histological analysis of methylene blue–stained semithin sec-
tions revealed obvious structural anomalies in the skin of the 
homozygous mutant mice (Fig. 7, A–C). Numerous vacuole-
like structures were observed in the upper granular layers of the 
epidermis underlying the stratum corneum. The vesicles were 
variable in size and irregularly distributed. Ultrathin section 
EM confi  rmed these fi  ndings at higher resolution (Fig. 7, D–L). 
Although no gross differences could be detected in the horny 
layers of the skin from the Alox12b
−/− mice, the cells of the 
Figure 4.  Defective development of skin permeability barrier in 12R-
LOX
−/− mice. (A) Barrier-dependent dye exclusion assay on wild-type and 
12R-LOX
−/− mice at the ages indicated. In control embryos, a decrease in 
skin permeability was observed from E16.5 to E17.5 as the barrier is ac-
quired in the dorsal to ventral pattern, whereas 12R-LOX
−/− embryos re-
mained completely stained. (B) Lucifer yellow dye penetration assay of 
newborn wild-type and 12R-LOX
−/− mice. Dye penetration (green ﬂ  uores-
cence) across the stratum corneum was observed in skin of 12R-LOX
−/− 
mice, but not in controls. Sections were counterstained with propidium iodide 
(red ﬂ  uorescence). The dotted line shows the border of stratum corneum–
stratum granulosum, the dashed line shows the epidermal–dermal junction. 
Bars, 20 μm.
Figure 5.  Histological analysis of 12R-LOX
−/−skin. Representative skin 
sections from newborn wild-type and 12R-LOX
−/− littermates stained with 
hematoxylin and eosin. Staining shows a more tightly packed SC, but an 
otherwise normal stratiﬁ  ed organization of keratinocytes in knockout skin. 
sc, stratum corneum; sg, stratum granulosum; ss, stratum spinosum; sb, 
stratum basale. Bars, 20 μm.
Figure 6.  Aberrant processing of proﬁ  laggrin. Equal amounts of protein 
extracts from wild-type (+/+), heterozygous (+/−), and homozygous mu-
tant (−/−) epidermis were separated trough SDS-PAGE and subjected to 
Western blot analysis using speciﬁ  c antibodies against keratin 10 (K10), 
keratin 5 (K5), loricrin (Lor), β-actin (Act), ﬁ   laggrin (Fil), and involucrin 
(Inv). Note the aberrant proﬁ  laggrin–ﬁ  laggrin processing in the knockout 
epidermis with the complete loss of the ﬁ  laggrin monomers and the accu-
mulation of proteolytically derived intermediates (arrows).12R-LOX AND EPIDERMAL BARRIER • EPP ET AL. 177
granular layer regularly contained vesicular structures of variable 
sizes (Fig. 7 E, asterisks). Sometimes they seemed to have fused. 
Most vesicles were electron-lucent with some smaller vesicles 
inside (Fig. 7, I and K). At higher magnifi  cations, we could 
  observe lamellar structures adhering to the surrounding mem-
brane (Fig. 7, J and L). Normal looking lamellar bodies were 
also present (Fig. 7 F). Using ruthenium tetroxide after fi  xation, 
the typical lipid lamellae within lamellar bodies (Fig. 7 G), as 
well as the stacks of lipid lamellae representing extruded con-
tent of lamellar bodies in the transition zone between the last 
granular cell layer and the fi  rst cornifi  ed cell (Fig. 7 H), could 
be visualized. No difference in respect to the organization of the 
stacks or number of lamellae could be determined so far.
Increased fragility of corniﬁ  ed envelope (CE)
We prepared CEs from control and 12R-LOX
−/− newborn epi-
dermis to assess morphology and resistance to mechanical 
stress. Microscopic examination revealed no obvious structural 
abnormalities of the CEs isolated from mutant mice. Upon ul-
trasound treatment, however, the percentage of intact corneo-
cytes from homozygous mutant mice decreased signifi  cantly 
(P > 0.01) faster with time, compared with CEs from wild-type 
and heterozygous littermates, indicating an increased fragility 
of the mutant CEs (Fig. 8).
Altered lipid composition
The structural anomalies in the skin of 12R-LOX–null mice in-
dicated that defects in the lipid metabolism may be associated 
with the observed phenotype. It is well known that lipid constit-
uents, such as free fatty acids, cholesterol, and ceramides, play 
an important role in epidermal barrier function. On the extracel-
lular surface of the CE there is a covalently bound layer of very 
long chain ω-hydroxyceramides and ω-hydroxy-fatty acids, 
called the lipid envelope. The exact function of the lipid envelope 
still remains unclear, but there is evidence that interactions of 
protein-bound lipids with free intercellular lipids contribute to 
the patterned organization of the lamellae seen in EM (Madison, 
2003). It has been shown that alterations in lipid composition of 
free or protein-bound lipids impair barrier function of the skin 
and lead to an increased TEWL (Meguro et al., 2000; Macheleidt 
et al., 2002). We thus determined the levels of these lipids in the 
skin of wild-type and mutant mice. The levels of total fatty acids, 
Figure 7.  Ultrastructural anomalies in 12R-LOX
−/− mice. 
(A–C) Methylene blue staining images of semithin sections 
from newborn dorsal skin of wild-type (A) and knockout 
mice (B and C). Arrows indicate irregular vesicular struc-
tures in the upper granular layers of the knockout skin. 
(D–L) Back skin of wild-type (D) and 12R-LOX
−/− (E–L) 
mice was processed for transmission EM. (D) Normal 
horny and granular layer in wild-type epidermis. Asterisks 
depict keratohyalin granules. (E) Abnormal vesicular struc-
tures (asterisks) within granular layer. (F) Normal lamellar 
bodies (arrows) within granular layer. (G) Normal lamel-
lar body; improved presentation of lamellae stacks by 
  ruthenium tetroxide postﬁ  xation. (H) Improved visualization 
of lipid lamellae stacks between uppermost epidermal cell 
and ﬁ  rst keratinized cell. (I and J) Membranous material 
resembling the content of lamellar bodies adheres to the 
marginal membrane of irregular vesicles (arrows). (K and L) 
Details of irregular vesicles; membranous material and 
small vesicle. Bars: (A–C) 10 μm; (D) 2.25 μm; (E) 3 μm; 
(F) 500 nm; (G and H) 50 nm; (I and J) 513/250 nm; 
(K and L) 500/200 nm.JCB • VOLUME 177 • NUMBER 1 • 2007  178
cholesterol, and total free ceramides were not substantially dif-
ferent between control and 12R-LOX–defi  cient mice (not de-
picted). In the free ceramide fraction, we found mainly ceramide 
EOS, NS, and NP, as well as two ceramide AS species (Fig. 9). 
These results are in accordance with previously published results 
(Doering et al., 1999, 2002). However, in the protein-bound frac-
tion, fi  ve different species could be detected on HPTLC (B1–5). 
The exact identities of these species still have to be elucidated, 
but B4 is possibly ceramide OS. Signifi  cant differences were 
found in the subfractions of ester-bound lipids between wild-
type and knockout mice. Whereas species B1 was found signifi  -
cantly increased, three other species (B2, B4, and B5) were 
almost completely absent in knockout epidermis (Fig. 9).
Discussion
We report the successful targeted disruption of Alox12b in mice, 
which refl  ects features of ARCI and shows that 12R-LOX has a 
crucial role in the establishment of the epidermal barrier.
The epidermis is a self-renewing stratifi  ed epithelium that 
serves as a protective barrier against mechanical, chemical, and 
biological insults; it is also a water-impermeable barrier that 
prevents excessive loss of body fl  uids. This function is critical 
for the survival of all terrestrial vertebrates and is established 
during late embryonic development. Identifi  cation of the mo-
lecular nature of the barrier is still under investigation. There 
is consent, however, that specialized structures in the stratum 
Figure 8.  Increased fragility of mutant CE. CEs were iso-
lated from 12R-LOX
−/− and wild-type epidermis, and 
samples of 5 × 10
6 CEs in 0.5 ml extraction buffer were 
treated with ultrasound at 4°C. (A) At indicated time 
points, 5-μl aliquots were removed, and the percentage of 
intact CEs was determined with the hematocytometer. 
Data are presented as the mean ± the SD. *, P < 0.01. 
(B) Morphological appearance of wild-type and knockout 
CEs. In untreated CEs, no clear difference between knock-
out and control skin was observed. After 20 min of treat-
ment, most mutant CEs were destroyed, whereas a large 
fraction of wild-type CEs were still intact. Shown is one of 
two independent experiments with similar results. Bars, 
100 μm.
Figure 9.  Altered ceramide composition of 12R-LOX
−/− 
epidermis. Free and ester-linked epidermal lipids were ex-
tracted and separated using TLC. Ceramides are classi-
ﬁ  ed as suggested in previous works (Motta et al., 1993; 
Robson et al., 1994). B1–5 are lipids extracted after alka-
line hydrolysis, most likely ester-linked epidermal lipids. 
(A) A representative TLC analysis of lipids extracted from 
wild-type and knockout epidermis. (B) Individual lipid lev-
els quantiﬁ   ed by densitometric analysis. Data are pre-
sented as the mean ± the SEM. n = 3. *, P < 0.01. 
Shown is one of two independent experiments with simi-
lar results.12R-LOX AND EPIDERMAL BARRIER • EPP ET AL. 179
corneum, the CE, and extracellular lipid lamellae, as well as 
tight junctions in the granular layers, play essential roles in the 
development of the skin barrier function (Tsuruta et al., 2002; 
Segre, 2003).
The stratum corneum is formed from granular cells during 
terminal differentiation as keratinocytes ascend from the prolif-
erative cell type in the basal layer through the spinous and gran-
ular layers to end up as fl   at, dead corneocytes within the 
cornifi  ed layer. The CE is assembled underneath the plasma 
membrane by sequential incorporation and transglutaminase-
mediated cross-linking of precursor proteins, followed by the 
covalent attachment of extracellular lipids. At the granular 
layer–stratum corneum interface, the lamellar bodies that are 
thought to be elements of the tubulovesicular TGN fuse with the 
cell membrane and extrude their contents to form a multilamel-
lar lipid complex that fi  lls most of the intercellular space.
Pathological abnormalities in the stratum corneum, with 
the subsequent breakdown of epidermal barrier function, are 
observed in various skin diseases, which are referred to as ich-
thyoses. The loss of barrier function can be caused by several 
defects in the molecular mechanisms involved in the proper as-
sembly of the CE or the intercorneocyte lipids. Several defec-
tive genes have been identifi  ed in ichthyosiform skin disorders 
so far, including genes coding for CE components (keratins, 
  loricrin, and fi  laggrin) and proteins involved in the assembly and 
protein turnover (transglutaminase 1 and LEKTI), and, most 
frequently, genes coding for enzymes involved in lipid meta-
bolism (e.g., fatty aldehyde dehydrogenase, steroid sulfatase, 
glucocerebrosidase, ATP-binding cassette transporter, (for review 
see Richard, 2004). Recent studies from our group and others 
have linked inactivating mutations in the genes of 12R-LOX 
and eLOX-3 to the development of ARCI (Jobard et al., 2002; 
Eckl et al., 2005).
12R-LOX is a member of the LOX multigene family, ex-
hibiting, among mammals, a unique R-stereospecifi  city of oxy-
gen insertion. The enzyme is found almost exclusively in skin. 
In mouse epidermis, a predominant mRNA expression was ob-
served in the differentiated keratinocytes (Sun et al., 1998; 
Heidt et al., 2000). By immunofl  uorescence analyses, we could 
now localize the 12R-LOX protein at the surface of the keratino-
cytes in the stratum granulosum, indicating a function in late 
epidermal differentiation. Interestingly, an almost identical ex-
pression pattern was observed for eLOX-3 (not depicted), sug-
gesting a colocalization of both LOX in the plasma membranes 
of the stratum granulosum. The implication of 12R-LOX and 
eLOX-3 in ARCI has brought forth the concept that both en-
zymes function in the same metabolic pathway to convert ara-
chidonic acid via 12R-HPETE to hepoxilin- and trioxilin-like 
metabolites that are critically involved in keratinocyte differen-
tiation (Jobard et al., 2002; Eckl et al., 2005; Yu et al., 2005; 
Lefevre et al., 2006). As shown for enzymes of the leukotriene 
synthesis, which form multimeric complexes in the nuclear 
membrane (Mandal et al., 2004), a coordinated membrane orga-
nization of these two enzymes, probably together with other en-
zymes and/or accessory proteins, may be a prerequisite for full 
enzyme activity and the proper generation of the bioactive lipid 
products of the 12R-LOX–eLOX-3 pathway in skin.
Indeed, under cell-free conditions, the recombinant hu-
man 12R-LOX exhibits only low catalytic activity converting 
arachidonic acid to 12R-HPETE, whereas the mouse enzyme 
does not metabolize free arachidonic acid, but only esterifi  ed 
substrates, including arachidonic acid and linoleic acid methyl 
esters (Siebert et al., 2001). This has raised the question as to 
the nature of the endogenous substrate and the functional ho-
mology of the mouse and human enzyme (Krieg et al., 1999; Yu 
et al., 2005, 2006). The results of this paper demonstrate an es-
sential role of 12R-LOX in the development of epidermal bar-
rier function in mice, documenting a functional homology of 
the mouse and human enzyme in skin.
12R-LOX–defi  cient mice exhibited the most severe pheno-
type regarding water barrier dysfunction reported so far. All 
knockout mice died within 3–5 h after birth as a result of severe 
dehydration. The mice lost  10% of their weight per hour. 
Other knockout mouse models with epidermal barrier defects, 
including mice defi  cient in KLF4 (Segre et al., 1999), claudin 
(Furuse et al., 2002), E-cadherin (Tunggal et al., 2005), LEKTI 
(Descargues et al., 2005), CAP1 (Leyvraz et al., 2005), and 
FATP4 (Herrmann et al., 2003), exhibited substantially less 
weight loss, resulting in a longer life span of the transgenic 
mice. Analyses of dye permeability and of TEWL clearly dem-
onstrated a severely defective inward and outward epidermal 
barrier function in 12R-LOX–defi  cient mice, while the barrier 
function of tight junctions was unaffected. The knockout mice 
failed to develop a functional epidermal barrier, which was ac-
quired in wild-type mice around E17. At this time point, expres-
sion of 12R-LOX, which starts in embryonic skin at E15.5, was 
shown to reach high levels that persists at later embryonic stages 
and in newborn skin (Sun et al., 1998).
Defective skin barrier function typically results in com-
pensatory mechanisms involving epidermal hyperproliferation, 
hyperkeratosis, and/or parakeratosis, which are observed fre-
quently in ichthyosiform human skin and various mouse models 
(Elias, 2004). 12R-LOX–defi  cient mice did not display such an 
obvious cutaneous phenotype, which may not develop because 
of the early neonatal lethality. In fact, markers of keratinocyte 
proliferation and terminal differentiation appeared to be unaf-
fected, with the exception of fi  laggrin.
This late terminal differentiation marker is the result of 
a complex proteolytic processing of profi  laggrin by several en-
zymes, including protein phosphatases, proteases, and protease 
inhibitors (Resing et al., 1984). Only mature fi  laggrin aggre-
gates keratin fi  laments to form macrofi  brils that crisscross the 
cornifi  ed cells of the stratum corneum, and it is an integral part 
of CE that contributes to its structural integrity. Thus, the de-
creased mechanical strength of CE from Alox12b
−/− mice may 
be caused by the reduced profi  laggrin processing. Furthermore, 
fi  laggrin monomers are degraded and provide free amino acids 
that, together with derivatives of amino acids and specifi  c salts, 
constitute the natural moisturizing factor that is involved in the 
hydration of the stratum corneum (Rawlings et al., 1994). Thus, 
reduction of fi  laggrin monomers might explain the more densely 
packed stratum corneum, which could contribute to the impaire-
ment of the barrier function in the mutant mice. In fact, dis-
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inactivation has been shown to be associated with impairment 
of barrier function in several mouse models (Presland et al., 
2000; List et al., 2002, 2003; Leyvraz et al., 2005; Descargues 
et al., 2005). In humans, lack of proteolytically processed fi  lag-
grin monomers caused by loss-of-function mutations have been 
shown to underlie ichthyosis vulgaris and discussed to be a ma-
jor predisposing factor for atopic dermatitis (Sandilands et al., 
2006; Smith et al., 2006).
An important component of the epidermal barrier is the 
arrangement of intra- and extracellular lipid accumulation in the 
stratum granulosum and stratum corneum, in particular the pro-
cessing of intracellular lipids and the process of their extrusion 
into the intercellular space. Ultrastructural analysis revealed 
structural anomalies in the upper granular layers of the skin of 
12R-LOX knockout mice that may refl  ect defects in the lipid 
metabolism associated with the observed phenotype. The fea-
tures of the abnormalities are reminiscent of characteristic alter-
ations found in a subgroup of ichthyosis congenital patients 
(Anton-Lamprecht, 1992). They include electron-lucent vesi-
cles of variable size with lamellar structures reminiscent of the 
content of lamellar bodies adhering to the surrounding mem-
brane. The appearance of these structures suggests that they 
may originate from defects in the assembly and/or extrusion of 
lamellar bodies, probably caused by aberrant lipid processing. 
Electron microscopic examination with ruthenium tetroxide 
postfi  xation to preserve lipid structure did not reveal major 
  disturbances of the intercellular lipid lamellae. However, we 
presently cannot exclude more subtle local disturbances of these 
structures. Nevertheless, this analysis refers to a specifi  c defect 
in lipid content and organization that may contribute to the 
  barrier impairment observed in Alox12b
−/− mice. Although the 
levels of total fatty acids, cholesterol, and free ceramides did 
not show substantial differences between control and mutant 
mice, we observed signifi  cant alterations in ester-bound lipids 
from Alox12b
−/− mice. Ceramides covalently attached to invo-
lucrin and other CE peptides are major constituents of the corni-
fi  ed lipid envelope that surrounds the corneocyte and have 
been discussed to be critical components of the barrier function 
(Elias et al., 2000; Doering et al., 2002). The identity of the lipid 
species altered in the 12R-LOX–defi  cient epidermis remains to 
be elucidated.
It also remains to be established weather 12R-LOX is di-
rectly involved in the enzymatic lipid processing or in the gen-
eration of lipid metabolites that are involved in the regulation of 
lipid metabolism. It is of interest to note that the epoxyalcohol 
metabolites produced by the 12R-LOX–eLOX-3 pathway are 
able to transactivate peroxisome proliferator-activated receptors 
(PPARs; Yu, 2005). Recent studies provide evidence for a role 
of PPARs in the regulation of terminal keratinocyte differentia-
tion, including lipid synthesis and processing (Di Poi et al., 
2004; Elias, 2005). Moreover, it was recently reported that 
PPAR activators are able to accelerate permeability barrier re-
covery after acute barrier disruption (Man et al., 2006).
In summary, this study indicates that the 12R-LOX–
eLOX-3 pathway plays a key role in the process of epidermal 
barrier acquisition by affecting lipid metabolism, as well as pro-
tein processing. 
Materials and methods
Generation of 12R-LOX–deﬁ  cient mice
Mouse genomic DNA for the targeting vector was cloned from a 129/ola 
mouse PAC library (clone RPCI-21 K13407Q2; obtained from P.J. de Jong 
and K. Osoegawa, Roswell Park Cancer Institute, Buffalo, NY). By using a 
7.4-kb BamHI fragment and a 4.4-kb PCR-generated fragment containing 
exon 7–12, a homology region was cloned into pBluescript KS+ (Strata-
gene) that spanned from 226 nt upstream of exon 3 to 1,081 nt downstream 
of exon 11 (Krieg et al., 1999). A tk/neo selection cassette ﬂ  anked by two 
loxP sites was inserted 230 bp upstream of exon 8, replacing a 222-bp 
AccI fragment; a third loxP site was inserted 84 bp downstream of exon 8, 
deleting a BamHI site (Fig. 1 A). The linearized targeting vector was electro-
porated into ES cells. Screening was done by PCR at both the 5′- and 3′-end 
using primer pairs consisting of one vector-speciﬁ  c primer and one endo-
genous Alox12b-speciﬁ  c primer located outside of the targeting region. The 
primers used were as follows: 5′-end screening, 5′-C  C  G  T  C  G  A  C  C  T  C  G  A  C-
C  A  G  C  C  T  G  T  C  T  A  C  A  -3′ and 5′-C  T  G  A  G  G  C  C  A  G  A  A  G  A  T  C  A  C  A  A  G  T  T  C  A  A  G  -
3′; 3′-end screening, 5′-G  A  G  G  C  A  T  C  C  G  G  G  G  A  T  C  A  T  A  A  C  T  T  C  G  T  A  T  A  -3′ and 
5′-C  A  G  G  T  A  T  A  G  T  T  C  G  C  A  A  G  C  A  G  G  T  G  G  -3′. Alox12b gene targeting was 
further veriﬁ  ed by Southern blot hybridization of BamHI-digested genomic 
DNA using 5′- and 3′-end probes ﬂ  anking the recombination arms (Fig. 1 A). 
Two homologous recombinants were identiﬁ   ed out of 300 analyzed. ES 
cells were injected into C57BL/6 blastocysts to generate chimeric mice, 
which were mated with C57BL/6 females. F1 heterozygotes (Alox12b
+/ﬂ  ox) 
were then crossed to 129S6. Mice were bred at the central animal facility 
of the German Cancer Research Center. All animals were kept under an 
artiﬁ  cial day/night rhythm and were fed standard food pellets (Altromin), 
with sterile water available ad libitum. The animal experiments were 
  performed in accordance with the guidelines of the Arbeitsmeinschaft der 
Tierschutzbeauftragten in Baden-Württemberg (Ofﬁ  cials for Animal Welfare) 
and were approved by the Regierrungspräsidum Karlsruhe, Germany.
To convert the targeted allele into a mutant allele structurally lacking 
the essential exon 8 of the Alox12b gene, F3 Alox12b
+/ﬂ  ox heterozygotes 
were crossed with CMV-Cre transgenic mice exhibiting ubiquitous Cre ex-
pression (Schwenk et al., 1995). Complete excision of the resistance cas-
sette and exon 8 in offspring mice was conﬁ  rmed by Southern blot and 
PCR analyses (Fig. 1 C). Heterozygous mutant mice (Alox12b
+/−) were 
bred with 129S6, and their heterozygous offspring were intercrossed to 
obtain homozygous mutant mice (Alox12b
−/−). Genotyping was per-
formed by PCR using 100 ng DNA isolated from tail and organs as a tem-
plate and the primers ol1231 (5′-A  C  C  C  T  C  C  C  C  T  G  C  T  G  C  T  G  T  T  G  C  -3′) and 
ol709 (5′-A  G  A  G  A  C  C  T  C  C  C  T  T  G  T  T  G  A  G  A  A  G  -3′) to distinguish the 459-bp 
mutant allele band from the 1,075-bp wild-type band (Fig. 1 D).
RNA isolation and RT-PCR
Total RNA was isolated from epidermis as previously described (Kinzig 
et al., 1999) and mRNA was reverse transcribed with MuLV reverse transcrip-
tase using the SuperScript II ﬁ  rst strand synthesis system (Invitrogen). The 
resulting cDNA was subjected to PCR with the primer pairs ol230 (5′-C  T  G-
T  G  C  C  C  C  G  A  T  G  T  G  C  T  T  G  C  T  G  -3′) and ol709 (3′-A  G  A  G  A  C  C  T  C  C  C  T  T  G  T  T  G-
A  G  A  A  G  -5′) for 12R-LOX. As a control, β-actin cDNA was ampliﬁ  ed as a 
housekeeping gene.
Antibodies
Rabbit polyclonal antipeptide antibodies against 12R-LOX and eLOX-3 have 
been previously described (Eckl et al., 2005). Mouse anti–12R-LOX mAb 
were raised using GST-12R-LOX fusion protein as immunogen. Other primary 
antibodies used were goat anti-actin (Santa Cruz Biotechnology), rabbit 
anti–Claudin-1, rabbit anti-occludin (both from Invitrogen), mouse anti-ﬁ  laggrin 
(Monosan), rabbit anti-keratin 5, rabbit anti-keratin 10, rabbit anti-involucrin, 
and rabbit anti-Ki67 (all from CRP). Secondary antibodies used were Alexa 
Fluor 488 goat anti–mouse IgG (Invitrogen), CY3 anti–rabbit IgG (BD Biosci-
ences), and anti–goat antibodies (Santa Cruz Biotechnology).
Epidermal protein extraction and Western blot analysis
Trunk epidermis of newborn mice was separated mechanically from the 
dermis after incubation for 30 s at 56°C in PBS. Epidermal proteins were 
extracted as described elsewhere (Tunggal et al., 2005; Leyvraz et al., 
2005), and Western blot analysis was performed as previously described 
(Eckl et al., 2005).
Histological and immunoﬂ  uorescence analysis
For light microscopic observation, samples were ﬁ  xed for 24 h with 4% 
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5-μm sections were mounted on slides, dewaxed, rehydrated, and stained 
with hematoxylin and eosin. For methylene blue staining, skin was ﬁ  xed 
with 1% glutaraldehyde for 24 h and embedded in epon. 1-μm sections 
were stained with methylene blue. For immunoﬂ  uorescence  microscopy, 
cryosections (3-μm thick) were ﬁ  xed in acetone for 10 min at −20°C and 
permeabilized with 0.05% Triton X-100 in PBS and ﬂ  ushed with PBS. The 
slides were blocked in 1% BSA in PBS for 1 h and incubated with the pri-
mary antibody for 1 h. After washing three times (10 min each) in PBS, 
samples were incubated with a ﬂ  uorescent dye coupled with antibody and 
Hoechst 33258 diluted in blocking buffer for 30 min and washed three 
times. Sections were embedded in mounting medium (DakoCytomation) 
and examined by light microscopy using a photomicroscope (Axioplan 2) 
with a 25× Plan-Neoﬂ  uar objective (both Carl Zeiss MicroImaging, Inc.). 
Images were acquired with a high sensibility digital black/white AxioCam 
(Carl Zeiss MicroImaging, Inc.).
Preparation of CEs and sonication experiments
CEs were puriﬁ  ed and sonicated at 4°C for various time points in a bath 
sonicator, as previously described (Koch et al., 2000).
Functional analyses of the epidermal barrier
To determine the rate of ﬂ  uid loss, newborns were separated from their 
mother and kept at 37°C. The body weight was monitored every 30 min, 
until time of death of homozygous mutant mice. The rate of TEWL from the 
skin of newborn mice was determined by using a Tewameter (Courage + 
Khazaka). For penetration assays, backs of newborn mice were immersed 
in 1 mM Lucifer yellow in PBS at 37°C. After 1 h incubation, mice were 
killed and the skin was dissected out. Frozen sections were counterstained 
with propidium iodide and penetration of the dye was assessed by immuno-
ﬂ  uorescence microscopy.
Toluidine blue staining of mouse embryos
The developmental stage of mouse embryos was determined based on the 
assumption that fertilization occurred in the middle of the dark cycle the 
day before plugs were identiﬁ  ed. The embryos were subjected to methanol 
dehydration and subsequent rehydration, as previously described (Koch 
et al., 2000), washed in PBS for 1 min, and stained for 30 min in 0.1% 
  toluidine blue O/PBS. After destaining in PBS for 15 min, the embryos 
were photographed.
EM
All specimens were ﬁ  xed for at least 2 h at room temperature in 3% glutar-
aldehyde solution in 0.1 M cacodylate buffer, pH 7.4, cut into pieces of 
 1 mm
3, washed in buffer, postﬁ  xed for 1 h at 4°C in 1% osmium tetroxide 
or in 0.5% ruthenium tetroxide, rinsed in water, dehydrated through 
graded ethanol solutions, transferred into propylene oxide, and embedded 
in epoxy resin (Glycidether 100; Merck). Ultrathin sections were treated 
with uranyl acetate and lead citrate and examined with an electron micro-
scope (EM 400; Philips).
Lipid analysis
Chemicals. Ceramide AS was purchased from Sigma-Aldrich. Ceramide 
NS was provided by Sederma, and ceramides EOS, EOP, NP, and AP 
were provided by Degussa.
Lipid extraction. Lipid extraction followed a previously described 
protocol (Doering et al., 1999) with slight modiﬁ  cations. In brief, epider-
mis homogenate was extracted twice, ﬁ  rst overnight with chloroform (meth-
anol 1:2 at room temperature) and second with 2 ml chloroform (methanol 
2:1 for 1 h at room temperature). The organic layers of both extraction 
steps were combined, the solvent was removed using a Christ Speed-Vac 
Alpha RVC/Alpha 2–4 (Christ), and the residue was redissolved in 100 μl 
methanol/chloroform at a 1:1 ratio.
For recovery of protein-bound lipids, the pretreated pellet was incu-
bated with 1 ml of 1 N NaOH in methanol at a ratio of 19:1, followed by 
extraction with 2 ml of chloroform for 1 h at 37°C. The organic layer was 
removed and washed with 3 ml of PBS–buffer; after phase separation, the 
solvent of the organic layer was evaporated in the Speed-Vac and the resi-
due was redissolved in 100 μl methanol/chloroform at a ratio of 1:1. Lipid 
extracts were stored at −20°C until use.
Lipid HPTLC. Analysis of epidermal lipids by HPTLC followed a previ-
ously described protocol (Farwanah et al., 2002). In brief, 50 μl of a sam-
ple were applied on a prewashed TLC plate, together with reference lipids, 
using an Automatic TLC Sampler 4 (CAMAG). The development of the 
plates has been performed automatically using an AMD-2 apparatus 
(CAMAG). The AMD procedure used included a 17-step gradient of decreas-
ing polarity, as previously described (Farwanah et al., 2002). After drying, 
the plates were sprayed with an aqueous solution of 10% CuSO4 (wt/vol), 
8% H3PO4 (vol/vol), and 5% methanol (vol/vol) using a ChromaJet DS20 
(Sarstedt), charred in a drying oven at 180°C for 30 min, and, ﬁ  nally, 
scanned using a TLC Scanner 3 (CAMAG). Integration and quantiﬁ  cation 
based on peak areas were performed using WinCATS software (CAMAG). 
Quantitative results for all ceramides were related to ceramide NP.
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